Go to the list of all blogs
Bort Wilson's Avatar
published in Blogs
Sep 26, 2026
CIBR vs HACK: Weighing Two Cybersecurity ETFs

CIBR vs HACK: Weighing Two Cybersecurity ETFs

Key Takeaways

  • Both ETFs provide targeted exposure to the cybersecurity theme through passive indexing strategies, but CIBR offers broader diversification with roughly twice as many holdings as HACK.
  • CIBR tracks the Nasdaq CTA Cybersecurity Index and maintains a net expense ratio of 0.58%, while HACK follows the Nasdaq ISE Cyber Security Select Index at 0.60%.
  • Top holdings overlap significantly in pure-play cybersecurity names such as PANW, CRWD, and FTNT, yet HACK incorporates a higher allocation to defense contractors including NOC and GD.
  • CIBR exhibits a more balanced sector profile with meaningful exposure across software, hardware, and select industrials, whereas HACK tends toward greater concentration in a smaller basket of names.
  • Structural differences in index construction and rebalancing frequency influence relative positioning, with both funds rebalanced quarterly and focused exclusively on companies where cybersecurity activities represent a core business driver.
  • In the current market environment, investors compare the two for cost efficiency, liquidity, and the degree of pure-play versus diversified cybersecurity exposure within the broader technology and industrials sectors.

Why Cybersecurity ETFs Continue to Draw Attention

Cybersecurity remains a durable secular growth theme driven by rising digitalization, regulatory requirements, and persistent threat landscapes. The CIBR and HACK both deliver pure-play exposure to companies whose primary business involves cybersecurity solutions. While they compete directly within the same thematic niche, structural distinctions in index methodology, number of holdings, and sector weighting create meaningful differences in risk and return profiles that warrant comparison for investors seeking targeted sector exposure. I also checked this using Tickeron’s AI Screener to see how the funds align with broader industry patterns.

A Closer Look at CIBR

The CIBR seeks to track the performance of the Nasdaq CTA Cybersecurity Index. The fund employs a passive strategy and holds approximately 44 securities, with a net expense ratio of 0.58%. It maintains at least 90% exposure to index constituents classified as cybersecurity companies by the Consumer Technology Association. Top holdings typically include PANW, CRWD, FTNT, CSCO, and AVGO. Sector allocations emphasize technology services and electronic technology, with smaller weights in industrials such as aerospace and defense. The index applies a modified liquidity-weighted methodology with concentration caps and undergoes quarterly rebalancing. CIBR is structured as an open-end fund listed on NASDAQ.

A Closer Look at HACK

The HACK seeks investment results that correspond to the Nasdaq ISE Cyber Security Select Index. Launched in 2014 as the first dedicated cybersecurity ETF, it follows a passive approach with approximately 23 holdings and a net expense ratio of 0.60%. The index focuses on companies where cybersecurity represents a key business driver, split between infrastructure providers and service providers. Prominent holdings often feature PANW, CRWD, AVGO, CSCO, and defense names such as NOC and GD. Sector exposure centers on technology with a notable industrials component. The index is reconstituted and rebalanced quarterly using market-capitalization weighting subject to caps. HACK trades on NYSE Arca as an open-end fund.

The Broader Industry Context

The cybersecurity sector benefits from sustained demand fueled by expanding attack surfaces, enterprise digital transformation, and evolving compliance mandates across industries. Macroeconomic factors including interest-rate expectations and corporate capital-spending cycles influence technology budgets, while geopolitical tensions can accelerate defense-related cybersecurity spending. Both ETFs operate within a non-diversified structure, exposing investors to concentrated thematic risks such as rapid technological change, competitive intensity, and regulatory developments in data privacy and export controls. Capital flows into cybersecurity-themed products have remained resilient through recent market cycles, reflecting the sector’s defensive growth characteristics amid broader equity volatility.

Performance Patterns and Positioning

Over recent market cycles, both ETFs have exhibited elevated volatility relative to broad equity benchmarks, driven by earnings sensitivity among top holdings and shifts in growth-stock sentiment. CIBR’s larger number of holdings generally supports modestly lower idiosyncratic risk and smoother relative performance during sector rotations. HACK’s more concentrated profile can amplify returns when defense and large-cap cybersecurity names lead, yet it may experience sharper drawdowns during periods of software-sector weakness. Relative positioning reflects differences in defense exposure and index weighting schemes, with performance divergences often tied to the earnings trajectories of shared holdings and broader macroeconomic drivers such as corporate IT spending and interest-rate paths. From what I see, these nuances matter when constructing a thematic allocation.

Using AI Tools in ETF Research

When evaluating thematic ETFs like these, I turn to Tickeron’s AI Screener to filter holdings by technical patterns, fundamentals, and sector trends. It helps surface comparable ideas quickly without manual effort, which supports more informed decisions on diversification and risk. This approach has proven useful for refining exposure in areas such as cybersecurity.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CIBR, HACK

Contributor

Bort Wilson's AvatarBort Wilson|Beginner

With a background in economics and swing trading, I write about market trends, technical setups, momentum, and opportunities that develop over several days or weeks. I combine economic perspective with practical trading experience to explain why stocks move, what trends may be developing, and which market signals are worth watching.


CIBR's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CIBR turned positive on September 15, 2026. Looking at past instances where CIBR's MACD turned positive, the stock continued to rise in 43 of 46 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 14, 2026. You may want to consider a long position or call options on CIBR as a result. In 65 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

CIBR moved above its 50-day moving average on September 11, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where CIBR advanced for three days, in 313 of 363 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 261 of 302 cases where CIBR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CIBR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOGL), Microsoft Corp (NASDAQ:MSFT), Broadcom Inc. (NASDAQ:AVGO), Cisco Systems (NASDAQ:CSCO), Palo Alto Networks Inc (NASDAQ:PANW), Arista Networks Inc (NYSE:ANET), Crowdstrike Holdings Inc (NASDAQ:CRWD), International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Datadog (NASDAQ:DDOG).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq CTA Cybersecurity Index TM (the "index"). The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as "cyber security" companies by CTA. The fund is non-diversified.

Market Cap

The average market capitalization across the First Trust NASDAQ Cybersecurity ETF (CIBR) ETF is 202.71B. The market cap for tickers in the group ranges from 1.24B to 4.19T. GOOGL holds the highest valuation in this group at 4.19T. The lowest valued company is RDWR at 1.24B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust NASDAQ Cybersecurity ETF (CIBR) ETF was 1%. For the same ETF, the average monthly price growth was 8%, and the average quarterly price growth was 66%. DDOG experienced the highest price growth at 17%, while GEN experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the First Trust NASDAQ Cybersecurity ETF (CIBR) ETF was -29%. For the same stocks of the ETF, the average monthly volume growth was 80% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 48
Price Growth Rating: 39
SMR Rating: 57
Profit Risk Rating: 70
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
CIBR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Technology

Category
Technology
Address
First Trust Exchange-Traded Fund II12o East Liberty Drive, Suite 400Wheaton
Phone
630-241-4141
Web
www.ftportfolios.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.